Feds Bet on Wrong COVID Horse Again as Pfizer’s Own Research Casts Doubt on Pricey Paxlovid

Pfizer Research and Development lab La Jolla, CA

There may be a reason Pfizer chose that curious tagline in the drugmaker’s once-inescapable commercials for its COVID-19 oral antiviral – the subject of a “Saturday Night Live” parody – which cost U.S. taxpayers at least $12 billion before the feds tightened the spigot last fall and Pfizer jacked the price to $1,390 for a five-day course.

The nirmatrelvir-ritonavir combination marketed as Paxlovid does no better against so-called long COVID than a placebo taken with ritonavir, according to a new “original investigation” quietly released Friday in JAMA Internal Medicine, published by the Journal of the American Medical Association.

Read More

‘Unacceptable Incompetence’: CDC Made Dozens of Basic Data Errors on COVID, Epidemiologists Find

Sick person talking to CDC employee

The Center for Disease Control and Prevention (CDC) found itself hoist with its own petard by making 25 basic statistical and numerical errors related to COVID-19, particularly with regard to children, while purporting to expose COVID vaccine misinformation, according to an analysis led by University of California San Francisco epidemiologists.

The preprint, which has not yet been peer-reviewed, documented 20 errors that “exaggerated the severity of the COVID-19 situation” and three that “simultaneously exaggerated and downplayed” severity, while one each was neutral or exaggerated vaccine risks.

Read More

President Biden Tests Positive for COVID-19 Again

President Biden on Saturday tested positive for COVID-19 again, the White House state in a statement.

A statement was from the White House physician and said the 79-year-old president tested positive “late Saturday morning” after multiple negative tests earlier in the week. He returned to in-person work Wednesday, after having tested positive days earlier. The situation of getting COVID soon after having already contracted the virus is frequently referred to as “rebound” COVID.

Read More

FDA Authorized First COVID-19 Antiviral Pill in U.S.

The FDA on Wednesday authorized the first COVID-19 antiviral pill in the U.S.

The Pfizer pill, Paxlovid, will be prescribed for use in adults and children 12 and older who have mild to moderate virus symptom and at risk for severe disease or hospitalization, according to a Food and Drug Administration statement obtained by NBC News.

Read More